Skip to content
Screener

ICU Medical ICUI Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$547.9MBeat by $14.4M
EPS$2.37Beat by $0.46
Revenue estimate$533.4M
EPS estimate$1.91
“Second quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”
Vivek Jain

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$552.1M
EPS estimate$2.13

Financials

Q2 2026

Income statement

See full
Revenue$551.7M+0.5%
Gross profit$235.1M+13.0%
Operating income$39.1M+270%
Net income$19.1M-46.0%
EPS (diluted)$0.76-46.9%

Balance sheet

See full
Cash & equivalents$298.3M-0.6%
Total debt$1.3B-7.1%
Total equity$2.2B+1.7%
Total assets$4.0B-3.3%

Cash flow

See full
Operating cash flow$80.2M+615%
CapEx$18.5M-6.0%
Free cash flow$61.6M—

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$3.9B+21.1%
Enterprise value$4.91B+13.5%
P/E48×—
P/S1.8×+0.4×

Profitability

See full
Gross margin39.1%+3.3pp
Operating margin3.3%+0.4pp
FCF margin7.1%+4.2pp

Returns & leverage

See full
Debt / equity0.6×-0.1×
Current ratio2.4×0.0×

FAQ

When did ICU Medical report Q2 2026 earnings?
ICU Medical (ICUI) reported Q2 2026 earnings on August 6, 2026 after market close.
What were ICU Medical's Q2 2026 revenue and EPS?
ICU Medical reported revenue of $547.9M and eps of $2.37 for Q2 2026.
Did ICU Medical beat estimates in Q2 2026?
Revenue beat the consensus estimate of $533.4M by $14.4M. EPS beat the consensus estimate of $1.91 by $0.46.
How did ICU Medical's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.2% from $548.9M a year earlier and eps grew 12.9% from $2.10.
Where can I find ICU Medical's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000883984-26-000040) and the 10-Q periodic report (0000883984-26-000041) directly on SEC EDGAR. The filing index links above go to sec.gov.